Should You Buy Amphenol Corp (APH) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
149.630
1 Day change
2.52%
52 Week Range
167.040
Analysis Updated At
2026/01/28
BUY now for a long-term beginner portfolio. APH is in a strong uptrend with accelerating fundamentals (very strong YoY growth) and Wall Street has been raising targets meaningfully. Price is stretched short-term (overbought) and earnings are tomorrow pre-market, but given you’re impatient and prefer long-term, the data still supports buying now rather than waiting for a perfect pullback.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Technical Analysis
Trend is bullish. Moving averages are stacked bullishly (SMA_5 > SMA_20 > SMA_200) and MACD histogram is positive and expanding (1.514), confirming upward momentum. However, RSI_6 is very high at 82.44 (overbought), suggesting the stock is extended and could see a near-term dip or pause.
Key levels: Pivot ~154.93; resistance at R2 ~169.11. Pre-market ~168.68 is pressing into that upper resistance zone, so upside may be choppier near-term even if the bigger trend remains up.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Options positioning is mildly bullish: open interest put/call ratio 0.77 (more calls than puts) and volume put/call ratio 0.9 (near-balanced, slight call tilt).
Implied volatility is elevated (30D IV ~43.55) and IV percentile is very high (91.2), which typically signals the market is pricing a meaningful move—consistent with the imminent earnings event. This supports “event-driven” trading sentiment rather than complacent optimism.
Technical Summary
Sell
2
Buy
8
Positive Catalysts
1) Imminent earnings catalyst: QDEC 2025 earnings on 2026-01-28 (pre-market); market expects ~0.93–0.94 EPS on ~$6.22B revenue.
2) Acquisition-driven upside narrative: JPMorgan explicitly raised estimates/target citing the CommScope connectivity & cable solutions deal and projects ~30% annual earnings growth over the medium term.
3) Strong institutional behavior: Hedge funds are buying; buying amount up ~542% QoQ.
4) AI/data-center and connectivity demand tailwinds implied by analyst commentary and sector context.
Neutral/Negative Catalysts
1) Technical stretch: RSI indicates overbought conditions, increasing the chance of a near-term pullback.
2) Earnings risk tomorrow: with elevated IV, any miss/guidance disappointment can trigger a sharp drop.
3) Price is near a key resistance area (~169), which can cap near-term upside even in an uptrend.
4) Macro/event tape risk: Fed/mega-cap earnings week can increase volatility and correlation moves.
Recent trend: clearly improving sentiment with multiple price target raises and predominantly bullish ratings.
- JPMorgan (2026-01-27): PT raised to $185 (from $160), Overweight; cites CommScope deal and strong medium-term earnings growth potential.
- Truist (2025-12-19): PT raised to $180 (from $147), Buy; constructive on AI infrastructure capex tailwinds.
- Evercore ISI (2026-01-20): PT raised to $165, Outperform.
- Fox Advisors (2026-01-09): PT raised to $165, Outperform.
- Barclays (2025-11-13): PT raised to $143, Equal Weight (more conservative, but still raised).
Wall Street pros: strong growth trajectory, M&A-driven expansion, exposure to AI/connectivity buildout. Cons: valuation/expectations likely elevated after a strong run, and near-term execution risk around earnings and integration.
Wall Street analysts forecast APH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for APH is 156.91 USD with a low forecast of 115 USD and a high forecast of 180 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast APH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for APH is 156.91 USD with a low forecast of 115 USD and a high forecast of 180 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
1 Hold
0 Sell
Strong Buy
Current: 145.960
Low
115
Averages
156.91
High
180
Current: 145.960
Low
115
Averages
156.91
High
180
Barclays
Guy Hardwick
Overweight
maintain
$156 -> $175
AI Analysis
2026-01-29
New
Reason
Barclays
Guy Hardwick
Price Target
$156 -> $175
AI Analysis
2026-01-29
New
maintain
Overweight
Reason
Barclays analyst Guy Hardwick raised the firm's price target on Amphenol to $175 from $156 and keeps an Overweight rating on the shares following the Q4 report. The share selloff on the company's below-consensus Q1 sales outlook provides an opportunity, the analyst tells investors in a research note. The firm says Amphenol posted broad-based end market growth and a record order book of $8.4B
Citi
Asiya Merchant
Buy
maintain
$175 -> $180
2026-01-29
New
Reason
Citi
Asiya Merchant
Price Target
$175 -> $180
2026-01-29
New
maintain
Buy
Reason
Citi analyst Asiya Merchant raised the firm's price target on Amphenol to $180 from $175 and keeps a Buy rating on the shares. The stock sold off post earning despite "strong" results, the analyst tells investors in a research note. Citi says Amphenol typically issues conservative guidance.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for APH
